Chemotherapy dosing part II

alternative approaches and future prospects

S. A. Kaestner, Graham J. Sewell

Research output: Contribution to journal › Article

13 Citations (Scopus)

Abstract

This overview follows on from part I, which described the current practices used in chemotherapy dosing and the paucity of scientific evidence to support them. In part II, alternative approaches are discussed, both in terms of scientific rationale and practical application. These include therapeutic drug monitoring, the use of pharmacokinetic-pharmacodynamic relationships, flat-fixed dosing, Bayesian modelling and dose banding.
Original languageEnglish
Pages (from-to)99-107
Number of pages9
JournalClinical Oncology
Volume19
Issue number2
DOIs
Publication statusPublished - Mar 2007

Fingerprint

Drug Monitoring
Pharmacokinetics
Drug Therapy

Cite this

Chemotherapy dosing part II : alternative approaches and future prospects. / Kaestner, S. A.; Sewell, Graham J.

In: Clinical Oncology, Vol. 19, No. 2, 03.2007, p. 99-107.

Research output: Contribution to journal › Article

Kaestner, SA & Sewell, GJ 2007, 'Chemotherapy dosing part II: alternative approaches and future prospects', Clinical Oncology, vol. 19, no. 2, pp. 99-107. https://doi.org/10.1016/j.clon.2006.10.003
Kaestner SA, Sewell GJ. Chemotherapy dosing part II: alternative approaches and future prospects. Clinical Oncology. 2007 Mar;19(2):99-107. https://doi.org/10.1016/j.clon.2006.10.003
Kaestner, S. A. ; Sewell, Graham J. / Chemotherapy dosing part II : alternative approaches and future prospects. In: Clinical Oncology. 2007 ; Vol. 19, No. 2. pp. 99-107.
@article{1a3900eaa16e4f1686a19f5c5487da0f,
title = "Chemotherapy dosing part II: alternative approaches and future prospects",
abstract = "This overview follows on from part I, which described the current practices used in chemotherapy dosing and the paucity of scientific evidence to support them. In part II, alternative approaches are discussed, both in terms of scientific rationale and practical application. These include therapeutic drug monitoring, the use of pharmacokinetic-pharmacodynamic relationships, flat-fixed dosing, Bayesian modelling and dose banding.",
author = "Kaestner, {S. A.} and Sewell, {Graham J.}",
note = "ID number: ISI:000244584000001",
year = "2007",
month = "3",
doi = "10.1016/j.clon.2006.10.003",
language = "English",
volume = "19",
pages = "99--107",
journal = "Clinical Oncology",
issn = "0936-6555",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Chemotherapy dosing part II

T2 - alternative approaches and future prospects

AU - Kaestner, S. A.

AU - Sewell, Graham J.

N1 - ID number: ISI:000244584000001

PY - 2007/3

Y1 - 2007/3

N2 - This overview follows on from part I, which described the current practices used in chemotherapy dosing and the paucity of scientific evidence to support them. In part II, alternative approaches are discussed, both in terms of scientific rationale and practical application. These include therapeutic drug monitoring, the use of pharmacokinetic-pharmacodynamic relationships, flat-fixed dosing, Bayesian modelling and dose banding.

AB - This overview follows on from part I, which described the current practices used in chemotherapy dosing and the paucity of scientific evidence to support them. In part II, alternative approaches are discussed, both in terms of scientific rationale and practical application. These include therapeutic drug monitoring, the use of pharmacokinetic-pharmacodynamic relationships, flat-fixed dosing, Bayesian modelling and dose banding.

UR - http://dx.doi.org/10.1016/j.clon.2006.10.003

U2 - 10.1016/j.clon.2006.10.003

DO - 10.1016/j.clon.2006.10.003

M3 - Article

VL - 19

SP - 99

EP - 107

JO - Clinical Oncology

JF - Clinical Oncology

SN - 0936-6555

IS - 2

ER -

Access to Document